ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 184 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,114,000 | +652.2% | 41,642 | +395.7% | 0.00% | +300.0% |
| Q1 2021 | $414,000 | -42.9% | 8,400 | -51.3% | 0.00% | 0.0% |
| Q4 2020 | $725,000 | +216.6% | 17,231 | +244.6% | 0.00% | – |
| Q3 2020 | $229,000 | -53.6% | 5,000 | -37.5% | 0.00% | -100.0% |
| Q4 2019 | $494,000 | +2.5% | 8,000 | +17.6% | 0.00% | 0.0% |
| Q4 2018 | $482,000 | -88.2% | 6,800 | -86.6% | 0.00% | -88.9% |
| Q1 2018 | $4,102,000 | +244.4% | 50,694 | +149.8% | 0.01% | +200.0% |
| Q4 2017 | $1,191,000 | – | 20,290 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |